Wednesday, March 29, 2017
 
 
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
DCL, the Pioneers in Cosmeceuticals, Launches "#DCLswitch Skincare Challenge"
 
(March 20, 2017)

EAST HAVEN, Conn., March 20, 2017 /PRNewswire/ -- Dermatologic Cosmetic Laboratories (DCL), the global authority in skincare products, invites consumers to make the #DCLswitch and take the 10-Day Skincare Challenge to rejuvenate their skin. Through DCL's unique Total Skin approach, skin's four most important building blocks ? the stratum corneum, epidermis, dermal epidermal junction and dermis ? are targeted to achieve optimal skin health. By targeting these four layers with four essential active ingredients ? peptides, retinoids, Vitamin C and AHAs ? DCL offers the most comprehensive skincare line to not only correct skin conditions, but to also maintain overall skin health. Consumers can switch to a product that specifically pinpoints one of the four different core skin layers. 

  • Stratum Corneum - Skin Renewal Complex with glycolic acid and SPF
  • Dermis C-Scape High Potency Night Booster 30 with 30% L-ascorbic acid
  • Epidermis Hydra Boost Finishing Serum with hyaluronic acid
  • Dermal Epidermal Junction Peptide Plus Cream with active peptides

The #DCLswitch Skincare Challenge presents the perfect opportunity to break through the clutter of over-the-counter skincare failures and switch to a science-based, proven line. The 360 campaign will build awareness and showcase the incredible before-and-after results. Campaign highlights will be visual through Instagram contests, social media, influencer partnerships, and other sampling efforts, providing consumers ample access to easily switch products. The campaign will run through Mother's Day. To enter the challenge, go to: www.facebook.com/DCLskincare

"We know that once consumers try our luxurious products, they see and feel a difference in their skin. Our light-years-ahead technology delivers the most advanced science, coupled with a beautiful and luxurious sensorial experience," explains Cherry Robinson, DCL President.


Dermatologic Cosmetic Laboratories includes over 40 skin, hair and body products that target specific skincare needs, including: Age Prevention, Brightening, Anti-Aging, Retexturizing, Anti-Acne, Pore Refinement and Oil Control, Hydration, Skin Sensitivity, Suncare, Haircare, and Hand and Bodycare. Products are clinically tested, non-comedogenic, free of parabens, phthalates and formaldehyde, and are never tested on animals. DCL is currently available through dermatologists and at dclskincare.com.

Media Contact:
Kerry McGee
150988@email4pr.com 
646-722-3043

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dcl-the-pioneers-in-cosmeceuticals-launches-dclswitch-skincare-challenge-300426116.html

SOURCE Dermatologic Cosmetic Laboratories

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Surgery, Science, Other,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • More Evidence of the Link Between Gum Disease and Diabetes Points Out the Systemic Importance of Good Oral Health, says Dr. Peiman Soleymani
  • Interventional Radiology Market Growing at a CAGR of 6.7% During 2016 to 2021 - ReportsnReports
  • Dr. Natalie Geary selected as "Top Pediatrician of the Year" for 2017 by the International Association of Top Professionals (IAOTP).
  • Audiology Devices Market is Expected to Reach USD 12,715.3 Mn by 2023 - Credence Research
  • Global $20.99 Billion Ablation Devices Market 2017-2023: Oncology is Holding the Largest Revenue in 2016

    Cancer
  • COA Completely Disagrees with Draft MedPAC Medicare Part B Recommendations
  • Two South Florida Medical Facilities Choose Air Esscentials to Implement Innovative Hospital Environmental Scenting Programs
  • Ablation Devices Global Market - Forecast to 2023 - Improving Reimbursement Scenario in Established Markets is a Key Market Driver - Research and Markets
  • BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify
  • Liquid Biopsies That Can Screen and Detect Cancer Early Winning Over Investors
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines